6 crucial questions about AstraZeneca's vaccine

6 crucial questions about AstraZeneca's vaccine
Hollis Johnson/Business Insider

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.



Happy day-before-Thanksgiving! It's seeming like a pretty good time to log off and relax. For those looking for some holiday specific content, I was reminiscing this morning on some of my classic early BI stories. They include such gems as: how to have a (nutritionally) healthy Thanksgiving without sacrificing the good stuff, and how big turkeys are today compared to a few decades ago.

If you're more in the mood for a serving of healthcare news, I've got you covered there too.

Today: 6 unanswered questions about AstraZeneca and Oxford's shot, funding for healthcare startups could stall out in the last few weeks of the year, and a guide to how to interpret vaccine efficacy.


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

Read the full analysis from Andrew Dunn and Dr. Catherine Schuster-Bruce here>>

6 crucial questions about AstraZeneca's vaccine
Getty Images

2020 has been a record fundraising year for healthcare startups, but a new report cautions that funding could stall in the last few weeks

Read the full story from Megan Hernbroth here>>

How to interpret the 'efficacy' rates of coronavirus vaccines

Read the full story from Hilary Brueck here>>


More stories we're reading:

I'll be back in your inbox first thing Monday, so in the meantime, have a great long weekend!

- Lydia